Skip to content

META Turkiye logo

Main menu
    • Hakkımızda
      • Vizyon, misyon ve değerler
      • Çeşitlilik, eşitlik ve kapsayıcılık
      • Liderlerimiz
      • Yönetim Ekibi
      • Yönetim Kurulu
    • Çevre, Toplum & Denetim
    • İlkelerimiz
    • Tedarikçiler
    • Medya
    • Basın bültenleri
    • Yatırımcı ilişkilerine genel bakış
    • SEC dosyalaması
  • Ekibimize katılın

Bize Ulaşın

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA

  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom

  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Yönetim Kurulu

Organon Yönetim Kurulu, ilaç sektöründe çeşitliliğe sahip yönetim kurullarından biridir. Yöneticilerimiz, şirketin vizyonuna ulaşma yolunda bize özgün bakış açılarını katmaktadır.

Photo of Carrie Cox

Carrie Cox
Photo of Kevin Ali

Kevin Ali
Photo of Robert Essner

Robert Essner
Photo of Alan Ezekowitz

Alan Ezekowitz
Photo of Ma Fatima de Vera Francisco

Ma Fatima de Vera Francisco
Photo of Helene Gayle

Helene Gayle
Photo of Shelly Lazarus

Shelly Lazarus
Photo of Deborah Leone

Deborah Leone
Photo of Martha McGarry

Martha McGarry
Photo of Philip Ozuah

Philip Ozuah
Photo of Cynthia Patton

Cynthia Patton
Photo of Grace Puma

Grace Puma
Photo of Shalini Sharp

Shalini Sharp
META Turkiye logo

Şirket

  • Hakkımızda
  • Liderlerimiz
  • Çevre, Toplum & Denetim

Kaynaklar

  • Hasta kaynakları
  • Yatırımcı ilişkileri
  • Medya

Bizimle iletişime geçin

  • Bizimle iletişime geçin
  • İletişim bilgisi
  • Global Lokasyonlar
  • İleriye Dönük Açıklama
  • Çerez politikası
  • Gizlilik Politikası
  • KULLANIM ŞARTLARI
  • Site haritası
Telif hakkı © Organon şirketler grubuna aittir. Tüm hakları saklıdır.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept